Pim-induced increase in the nuclear localization of N1ICD is observed in both cultured cells and in orthotopic prostate cancer xenografts, while Pim inhibitors or mutagenesis of the phosphorylation target site have opposite effects. This evidence concerns the gene PIM1 and prostate carcinoma.